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The role of prophylactic antibiotics in mesh repair of inguinal hernia is unclear. A Cochrane meta-analysis
in 2005 concluded that “antibiotic prophylaxis for elective inguinal hernia repair cannot be ﬁrmly rec-
ommended or discarded” and “further studies are needed, particularly on the use for mesh repair.” So,
we designed a study to deﬁne the role of prophylactic antibiotics in mesh repair of inguinal hernia.
We conducted a prospective, randomized, double-blind, trial comparing wound infection rates in 450
patients (225 received intravenous Cefazolin, 225 received a placebo) undergoing primary inguinal
hernia repair electively using polypropylene mesh. 334 patients who completed a followup period of one
month were analyzed. Age, American Society of Anesthesiologists class, type of hernia, type of anes-
thesia, grade of surgeon, pre and postoperative hospital stay and duration of operation were recorded.
CDC criteria was used to deﬁne wound infection.
Groups were well matched for all preoperative variables studied. The overall infection rate was 8.7%
(29 out of 334). The incidence of wound infection in antibiotic group was 7% and 10.5% in control group.
One from each group developed deep surgical site infection. Most of the infections occurred between the
7th and 12th post-operative day after discharge from the hospital.
Antibiotic prophylaxis was associated with decreased incidence of wound infection when compared to
control group, but the difference was not statistically signiﬁcant. Based on our results we do not
recommend the routine use of antibiotic prophylaxis in elective mesh repair of inguinal hernias.
 2010 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Inguinal hernia repair is one of the most common procedures
performed by general surgeons. It is estimated that 3,000,000
inguinal herniorrhaphies are performed per year in the United
States, Europe and Asia.1 Inguinal hernia repair is considered as
a clean surgery, where prophylactic antibiotics do not have any role,
at least in non-mesh repairs. Even though hernia is classiﬁed as
a clean surgery, the reported incidence of wound infection varies
from 0% to 9%.2 As more and more surgeries are done as day care
procedures, many of these infections are often recognized ﬁrst in
the outpatient setup, after discharge from the hospital.3
The role of prophylactic antibiotics in mesh repair of inguinal
hernia is unclear. The ﬁrst randomized control trial on the role of
antibiotic prophylaxis in mesh repair of inguinal hernia was done
in 2001 by Yerdel et al., who advocated the use of prophylactic
antibiotics.4 However, subsequent trials have produced varied
results. A Cochrane meta analysis on this topic in 2004 concludedG. Shankar).
ciates Ltd. Published by Elsevier Ltthat antibiotic prophylaxis in mesh repair of inguinal hernias can
neither be recommended nor discarded.5 Hence, we designed this
study to deﬁne the role of prophylactic antibiotics in prevention
of wound infection in mesh inguinal hernia repair and to analyze
the risk factors for wound infection in mesh inguinal hernia
repair.2. Patients and methods
The study was conducted in the department of general surgery,
JIPMER. It was a prospective randomized controlled study.2.1. Inclusion criteria
All consecutive patients with primary unilateral or bilateral
uncomplicated inguinal hernia who underwent mesh repair during
a period of twenty months from November 2006 to June 2008 in
the department of general surgery in our institute were included in
our study. Out of the 571 patients who underwent meshplasty
during the study period, 121 patients were excluded as per the
exclusion criteria given below:d. All rights reserved.
Table 1
Baseline characteristics.
Antibiotic group Control group Total p Value
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2. Immuno suppressive disease (HIV, Malignancy) or medication
3. Diabetes mellitusn (%) n (%) n (%)
Agea (in years) 44.44 15.59 45.56 16.43 44.99 15.99 0.523
Sexb
Male 171 (99.4%) 159 (98.1%) 330 (98.8%) 0.358
Female 1 (0.6%) 3 (1.9%) 4 (1.2%)
ASA gradeb
ASA I 157 (91.3%) 151 (93.2%) 308 (92.2%) 0.511
ASA II 15 (8.7%) 11 (6.8%) 26 (7.8%)
Co morbidityb
Present 24 (14%) 11 (6.8%) 35 (10.5%) 0.050
Absent 148 (86%) 151 (93.2%) 299 (89.5%)
Type of herniab
Unilateral 151 (87.8%) 156 (96.3%) 307 (91.9%) 0.005
Bilateral 21 (12.2%) 6 (3.7%) 27 (8.1%)
a Values expressed in mean standard deviation.
b Values expressed in numbers and percentage.
Table 2
Operative data.
Antibiotic
group
Control
group
Total p Value
Preoperative stay
(in days)a
4.38 3.11 3.93 3.00 4.16 3.06 0.178
Anesthesiab
SA 153 (89%) 142 (87.7%) 295 (88.3%) 0.695
GA 5 (2.9%) 7(4.3%) 12 (3.6%)
LA 13 (7.6%) 13(8.0%) 26 (7.8%)
Epidural 1 (0.6%) 1 (0.3%)
Grade of surgeonb
Consultant 25 (14.5%) 13 (8.1%) 38 (11.4%) 0.084
Resident 147 (85.5%) 149 (92%) 296 (88.6%)
Duration ofa surgery
(in minutes)
53.54 15.82 52.60 15.28 53.06 15.56 0.582
a Values expressed in mean standard deviation.
b Values expressed in numbers and percentage.2.2. Surgery and post operative management
After informed consent, 450 patients were randomized into
antibiotic group and control group by sealed envelope method on
the day before the surgery. Patients in the antibiotic group received
injection Cefazolin 1 g intravenously at the time of induction of
anesthesia. Normal saline was used as the placebo in the control
group.
Ioprep was the antiseptic used for skin preparation in all
patients. Groin shaving was done the day before surgery. All
patients underwent a standard tension free mesh repair using
a polypropylene mesh. A standard sterile dressing was applied post
operatively. No post operative antibiotics were used. Dressings
were removed at 48 h after surgery, when the ﬁrst wound
inspection was done. No further dressings were applied. Patients
were discharged at the discretion of the operating surgeon.
2.3. Followup
Wounds were inspected daily during the hospital stay and the
next followup visit was scheduled 7e10 days later when the
patients came for suture removal.
All patients were educated about the symptoms and signs of SSI
and were instructed to report to us in case they developed any such
symptoms and signs. The next wound inspection was scheduled on
the 30th post operative day. Followup was done by residents who
where blinded to the drug used. SSI was deﬁned as per the CDC
(Center for Disease Control) criteria.
2.4. Parameters studied
The parameters studied included the following:
1) Patient related factors like demographic data, ASA score
(determined by anesthesiologists preoperatively), preoperative
hospital stay, type of hernia and co morbid illnesses if any.
2) Surgery related factors like type of anesthesia, antiseptic used
for skin preparation, grade of surgeon, duration of surgery.
3) Incidence of surgical site infection.
The study was concluded in June 2008, by then, out of 450
patients who had entered the study, 334 patients had completed
one month followup.
2.5. Statistical analysis
Statistical analysis was done using SPSS statistical software. The
association between SSI and antibiotic status were analyzed using
chi square test. The effect of duration of surgery, hospital stay by
unpaired t-test and the grade of surgeon, ASA grade were analyzed
with Mann Whitney test.
3. Observations
Among the 334 patients with one month followup, 172 were in
the antibiotic group and 162 were in the control group. Demo-
graphic data were comparable between the two groups. Mean age
of the patients was 45, with range from 15 to 83 years. Majority of
the patients had unilateral hernia, while there were 27 bilateralhernias including both the groups. Most of the patients did not have
any associated co morbid illness (Table 1).
Surgery related factors like type of anesthesia, grade of surgeon
and duration of surgery were analyzed and were comparable in the
two groups. The mean duration of surgery was 53 minutes and was
comparable in the study groups. The mean pre-operative hospital
stay, mean post operative stay as well as the total hospital stay was
comparable in both the groups (Table 2).
29 patients (8.7%) out of the total of 334 patients developed
wound infection, out of which 12 patients belonged to the antibiotic
group and 17 patients belonged to the control group. There was no
statistically signiﬁcant difference in the incidence of wound infec-
tion between the study groups, even though the number of infected
patients was less in the antibiotic group (p¼ 0.344) (Table 3).
SSI was grouped as follows (using CDC criteria):
Superﬁcial SSI: Wound cellulitis/erythema/purulent discharge
from the wound
Deep SSI: Mesh infection.
No signiﬁcant difference was found between the study groups
on analyzing the sub types of infection.
Age, gender, ASA grade, co morbid illness, uni/bilateral hernia
did not have any signiﬁcant correlation with SSI rates (Table 4).The
grade of the surgeon did not have any statistically signiﬁcant
Table 3
Surgical site infection.
Infection Antibiotic group Control group Total p Value
n (%) n (%) n (%)
Present 12 (7%) 17 (10.5%) 29 (8.7%) 0.344
Absent 160 (93%) 145 (89.5%) 305 (91.3%) 0.344
Cellulitis 7 (4.1%) 5 (3.1%) 12 (3.6%) 0.128
Mesh infection 1 (0.6%) 1 (0.6%) 2 (0.6%) 0.128
Pus discharge 4 (2.3%) 11 (6.8%) 15 (4.5%) 0.128
Table 5
Correlation between operative variables and surgical site infection.
Infected group Uninfected group p Value
Preoperative stay (in days)a 5.31 3.16 4.06 3.03 0.035
Anesthesiab
SA 24 (82.8%) 271 (88.9%) 0.315
GA 1 (3.4%) 11 (3.6%)
LA 4 (13.8%) 22 (7.2%)
EPIDURAL 0 1 (0.3%)
Grade of surgeonb
Consultant 4 (13.8%) 34 (11.1%) 0.669
Resident 25 (86.2%) 271 (88.9%)
Duration of surgery (in minutes) 58.45 17.45 52.52 15.28 0.05
a Values expressed in mean standard deviation.
b Values expressed in numbers and percentage.
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surgery was 58.45 minutes in the group of infected patients when
compared to 52.52 minutes in patients without infection, which
was of borderline statistical signiﬁcance (p¼ 0.05) (Table 5).
Patients with wound infection had a signiﬁcantly longer preoper-
ative hospital stay (p¼ 0.035). The post operative stay was similar
in both groups. However, the total hospital stay was signiﬁcantly
longer in patients with wound infection (p¼ 0.001) (Table 6).
4. Discussion
The incidence of surgical site infection following mesh repair of
inguinal hernia has been ranging from 0% to 9%.3 Such a wide range
on SSI rates is due to the fact that studies differed in various aspects
like difference in study design (retrospective, non-randomized vs.
prospective, randomized), surveillance methods (surgical team vs.
independent observer), deﬁnition of wound infection (no deﬁnition
vs. CDC deﬁnitions), duration of follow-up, type of operation (mesh
repair vs. non-mesh repair).6 In our study, the overall infection rate
was 8.7%, in patients undergoing elective mesh repair of primary
inguinal hernias. The incidence of wound infectionwas 10.5% in the
control group and 7.0% in the antibiotic group. Even though the
incidence of wound infection was higher in the control group, it
was not statistically signiﬁcant (p¼ 0.344).
The power of the trial (a e 0.05, b e 80%,) was based on the
assumption that antibiotic prophylaxis will reduce the wound
infection rate from 8% (SSI Rates in our institute)7 to 1.7%(the SSI
rate in the largest RCT in this subject).8 The sample size calculated
was 348 patients. We expected a dropout of 20%, since the dropout
rate was higher than expected we continued the study till we had
450 patients.
The incidence of wound infection (8.7%) is higher in our study
when compared to other studies. An Earlier study7 done in our
institute revealed a SSI rate of 8% in Inguinal hernias. There is no
reliable data regarding the wound infection rates in the hospitals in
the developing world and given the fact that few trials4,9 even inTable 4
Correlation between patient parameters and surgical site infection.
Infected group Uninfected group p Value
Agea 48.00 16.32 44.70 15.95 0.289
Sexb
Male 29 301 1.000
Female 0 4
ASA gradeb
ASA I 26 (89.7%) 282 (92.5%) 0.591
ASA II 3 (10.3%) 23 (7.5%)
Co morbidityb
Present 3 (10.3%) 32 (10.3%) 0.980
Absent 26 (89.7%) 273 (89.5%)
Type of herniab
Unilateral 26 (89.7%) 281 (92.1%) 0.912
Bilateral 3 (10.3%) 24 (7.9%)the developed world have reported 8 to 9% SSI rates, our trial may
reﬂect the reality about SSI in developing countries.
The most common organism isolated was Staphylococcus aureus
(Table 7), which forms a part of normal skin ﬂora. Staphylococcus is
the most common isolate in surgical site infection following hernia
repair in various studies.4,7,10,11 Staph. aureus was the organism
isolated in 12 patients (70.5%) with culture positive infection. More
than one organism was isolated in 2 patients (11.7%) with culture
positive infection.
A few studies have shown that grade of the surgeon may be
a signiﬁcant risk factor for SSI.12 Majority of the procedures were
performed by residents in our study (n¼ 296), as ours is a teaching
institute. The grade of the surgeonwas not a statistically signiﬁcant
risk factor for SSI in our study. Taylor et al.13 in their study
concluded that the grade of the surgeon does not inﬂuence the rate
of SSI in groin hernia repair. Aufenacker et al.8 also reported similar
results from their study.
In our study, there is a positive correlation between the duration
of pre-operative hospital stay and the development of post opera-
tive SSI. The mean pre-operative hospital stay was 5.313.16 days
in the patients with SSI in comparison to 4.06 3.03 days in
patients without SSI. The difference was statistically signiﬁcant
(p¼ 0.035). It is a well known fact that increased preoperative
hospital stay increased the risk of colonization with resistant
bacteria.14 Since we do not have day care facility; all our patients
were operated as in patients, which is the reason for increased
preoperative hospital stay in our study. We believe that this will be
the case in majority of institutes in the developing world.
Only 2 (7%) out of 29 patients developedwound infection during
their hospital stay, whereas the vast majority (94%) were diagnosed
during followup, most often during their ﬁrst scheduled visit, in the
2nd post operative week. In the study done by Perez et al.10 on the
role of antibiotic prophylaxis in mesh repair, all the infections were
diagnosed after hospital discharge. This again emphasizes the need
for followup to establish the true incidence of SSI.
Vast majority of SSI occurring after hernia repair are superﬁcial
surgical site infection and are treated by simple drainage with or
without antibiotics.6 93% of the SSI in our study was superﬁcial SSI.
All the SSIs reported in the studies done by Celdran et al.9 and
Tzovaras et al.11 were superﬁcial SSI. The incidence of meshTable 6
Correlation between hospital stay and surgical site infection.
Infected group Uninfected group p Value
Post operative staya 3.38 3.86 2.5 1.3 0.070
Total hospital staya 9.69 4.37 7.53 3.10 0.001
a Values expressed in mean standard deviation (in days).
Table 7
Microorganisms in culture positive wound infections.
Micro organism Number (percentage)
Staphylococcus aureus 12 (70.5%)
Streptococci 2 (11.7%)
Klebsiella pneumoniae 2 (11.7%)
E. coli 1 (5.8%)
Enterobacteria 1 (5.8%)
Multiple organisms 2 (11.7%)
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incidence of deep SSI was 0.6% in our study. Aufenacker et al.8
reported an incidence of 0.3% for deep SSI in their study within
a followup period of 3 months. One patient had mesh removal due
to SSI in our study.
Cefazolin was the antibiotic used in our study. It was chosen
because of its proven efﬁcacy against the common organisms like
Staphylococcus aureus, longer duration of action and low cost.16
Since majority of SSI in our study were due to Staph. aureus, the
question of failure of prophylaxis due to inefﬁcient antibiotic is
ruled out. Cefazolin was the antibiotic used in studies done by
Celdran et al., Morales et al., and Perez et al.9,17,10 One gram of
Cefazolin was given intravenously at the time of induction of
anesthesia. This is consistent with the studies done by other
authors.
The economic impact of SSI was not assessed in our study.
However since 93% of infections were Superﬁcial SSIs, we believe
the cost effectiveness of antibiotic prophylaxis in the absence of
conclusive beneﬁt is questionable.
The incidence of wound infection was 9% in the control group
and 1% in the antibiotic group in the study done by Yerdel et al.4 The
authors showed a signiﬁcant difference in wound infection
between the antibiotic and control groups. Celdran et al.9 reported
SSI rates of 8% and 0% in the control and antibiotic group respec-
tively and had similar conclusions.
Aufenacker et al.8 showed that the incidence of SSI was 1.8% in
the control group and 1.6% in the antibiotic group. The author
concluded that prophylactic antibiotics did not prevent SSI in open
mesh repair of inguinal hernias. The SSI rates reported by Perez
et al.10 were 3.3% and 1.7% in the control and antibiotic group
respectively and the author did not ﬁnd any beneﬁt with prophy-
lactic antibiotics. A similar conclusion was drawn by Tzovaras
et al.,11 where the incidence of SSI in control and antibiotic groups
were 4.7% and 2.6% respectively. It should be noted that studies in
which the rates of SSI are higher have reported that prophylactic
antibiotics are beneﬁcial, whereas similar conclusion could not be
derived in the studies with low rates of SSI.
To conclude, in our study, even though the rates of SSI were high
in both the antibiotic and control groups, the difference was not
statistically signiﬁcant. Based on our results we conclude that
prophylactic antibiotics do not decrease the rate of SSI in meshrepair of inguinal hernias and hence routine use of prophylactic
antibiotics cannot be recommended for the same.
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